LARIMAR THERAPEUTICS, INC. Operating Income
LARIMAR THERAPEUTICS, INC. (LRMR) reported Operating Income of -$34.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-04
- LARIMAR THERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$34.35M.
- LARIMAR THERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$31.12M.
- LARIMAR THERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$64.02M.
- LARIMAR THERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$49.50M.
- LARIMAR THERAPEUTICS, INC. operating income (loss) for fiscal 2025 was -$172.50M.
- LARIMAR THERAPEUTICS, INC. operating income (loss) for fiscal 2024 was -$90.89M.
- LARIMAR THERAPEUTICS, INC. operating income (loss) for fiscal 2023 was -$41.76M.
- LARIMAR THERAPEUTICS, INC. operating income (loss) for fiscal 2022 was -$36.53M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$34.35M 10-Q · filed 2026-08-04 | -$65.47M 10-Q · filed 2026-08-04 | -$129.49M derived: sum of 3 quarters · filed 2026-08-04 | -$178.99M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$31.12M 10-Q · filed 2026-05-14 | -$95.14M derived: sum of 2 quarters · filed 2026-05-14 | -$144.63M derived: sum of 3 quarters · filed 2026-05-14 | -$172.43M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$64.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$113.52M derived: sum of 2 quarters · filed 2026-03-19 | -$141.31M derived: sum of 3 quarters · filed 2026-08-04 | -$172.50M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | -$49.50M 10-Q · filed 2025-11-05 | -$77.29M derived: sum of 2 quarters · filed 2026-08-04 | -$108.48M 10-Q · filed 2025-11-05 | -$139.77M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$27.79M 10-Q · filed 2026-08-04 | -$58.98M 10-Q · filed 2026-08-04 | -$90.27M derived: sum of 3 quarters · filed 2026-08-04 | -$108.54M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$31.19M 10-Q · filed 2026-05-14 | -$62.48M derived: sum of 2 quarters · filed 2026-05-14 | -$80.75M derived: sum of 3 quarters · filed 2026-05-14 | -$105.34M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$31.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$49.56M derived: sum of 2 quarters · filed 2026-03-19 | -$74.16M derived: sum of 3 quarters · filed 2026-03-19 | -$90.89M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | -$18.26M 10-Q · filed 2025-11-05 | -$42.86M derived: sum of 2 quarters · filed 2025-11-05 | -$59.60M 10-Q · filed 2025-11-05 | -$73.76M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$24.60M 10-Q · filed 2025-08-14 | -$41.33M 10-Q · filed 2025-08-14 | -$55.49M derived: sum of 3 quarters · filed 2025-08-14 | -$65.83M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$16.73M 10-Q · filed 2025-04-30 | -$30.90M derived: sum of 2 quarters · filed 2025-04-30 | -$41.23M derived: sum of 3 quarters · filed 2025-04-30 | -$50.85M derived: sum of 4 quarters · filed 2025-04-30 | ||||
| 2023-12-31 | -$14.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$24.50M derived: sum of 2 quarters · filed 2025-03-24 | -$34.12M derived: sum of 3 quarters · filed 2025-03-24 | -$41.76M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | -$10.34M 10-Q · filed 2024-10-30 | -$19.96M derived: sum of 2 quarters · filed 2024-10-30 | -$27.60M 10-Q · filed 2024-10-30 | -$38.03M derived: sum of 4 quarters · filed 2024-10-30 | ||||
| 2023-06-30 | -$9.62M 10-Q · filed 2024-08-08 | -$17.26M 10-Q · filed 2024-08-08 | -$27.70M derived: sum of 3 quarters · filed 2024-08-08 | -$36.21M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$7.64M 10-Q · filed 2024-05-09 | -$18.08M derived: sum of 2 quarters · filed 2024-05-09 | -$26.59M derived: sum of 3 quarters · filed 2024-05-09 | -$35.28M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$10.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$18.95M derived: sum of 2 quarters · filed 2024-03-14 | -$27.64M derived: sum of 3 quarters · filed 2024-03-14 | -$36.53M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$8.51M 10-Q · filed 2023-11-14 | -$17.20M derived: sum of 2 quarters · filed 2023-11-14 | -$26.09M 10-Q · filed 2023-11-14 | -$35.17M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$8.69M 10-Q · filed 2023-08-10 | -$17.57M 10-Q · filed 2023-08-10 | -$26.66M derived: sum of 3 quarters · filed 2023-08-10 | -$43.39M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$8.89M 10-Q · filed 2023-05-15 | -$17.97M derived: sum of 2 quarters · filed 2023-05-15 | -$34.70M derived: sum of 3 quarters · filed 2023-05-15 | -$47.25M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$9.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$25.82M derived: sum of 2 quarters · filed 2023-03-14 | -$38.36M derived: sum of 3 quarters · filed 2023-03-14 | -$50.47M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | -$16.73M 10-Q · filed 2022-11-10 | -$29.27M derived: sum of 2 quarters · filed 2022-11-10 | -$41.38M 10-Q · filed 2022-11-10 | -$55.77M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$12.54M 10-Q · filed 2022-08-11 | -$24.65M 10-Q · filed 2022-08-11 | -$39.05M derived: sum of 3 quarters · filed 2022-08-11 | -$49.38M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$12.11M 10-Q · filed 2022-05-12 | -$26.50M derived: sum of 2 quarters · filed 2022-05-12 | -$36.84M derived: sum of 3 quarters · filed 2022-05-12 | -$48.24M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$24.73M derived: sum of 2 quarters · filed 2022-03-25 | -$36.13M derived: sum of 3 quarters · filed 2022-03-25 | -$42.80M 10-K · filed 2022-03-25 | ||||
| 2020-09-30 | -$10.34M 10-Q · filed 2021-11-12 | -$21.73M derived: sum of 2 quarters · filed 2021-11-12 | -$28.41M 10-Q · filed 2021-11-12 | -$34.57M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$11.40M 10-Q · filed 2021-08-12 | -$18.07M 10-Q · filed 2021-08-12 | -$24.23M derived: sum of 3 quarters · filed 2021-08-12 | -$32.86M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$6.67M 10-Q · filed 2021-05-10 | -$3.56M 10-Q · filed 2020-05-07 | -$12.83M derived: sum of 2 quarters · filed 2021-05-10 | -$21.46M derived: sum of 3 quarters · filed 2021-05-10 | -$25.16M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | -$6.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$14.79M derived: sum of 2 quarters · filed 2021-03-04 | -$18.49M derived: sum of 3 quarters · filed 2021-03-04 | -$23.21M 10-K · filed 2021-03-04 | -$45.65M 10-K · filed 2020-03-05 | |||
| 2019-09-30 | -$8.63M 10-Q · filed 2020-11-12 | -$12.91M 10-Q · filed 2019-11-06 | -$12.33M derived: sum of 2 quarters · filed 2020-11-12 | -$17.06M 10-Q · filed 2020-11-12 | -$38.37M 10-Q · filed 2019-11-06 | -$40.30M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | -$3.70M 10-Q · filed 2020-08-14 | -$12.19M 10-Q · filed 2019-08-08 | -$8.43M 10-Q · filed 2020-08-14 | -$25.47M 10-Q · filed 2019-08-08 | -$31.67M derived: sum of 3 quarters · filed 2020-08-14 | -$46.84M derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | -$13.28M 10-Q · filed 2020-05-07 | -$27.97M derived: sum of 2 quarters · filed 2020-05-07 | -$43.14M derived: sum of 3 quarters · filed 2020-05-07 | -$58.70M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$14.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | -$29.86M derived: sum of 2 quarters · filed 2020-03-05 | -$45.42M derived: sum of 3 quarters · filed 2020-03-05 | -$61.12M 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | -$15.17M 10-Q · filed 2019-11-06 | -$30.73M derived: sum of 2 quarters · filed 2019-11-06 | -$46.43M 10-Q · filed 2019-11-06 | -$59.79M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2018-06-30 | -$15.56M 10-Q · filed 2019-08-08 | -$31.26M 10-Q · filed 2019-08-08 | -$44.62M derived: sum of 3 quarters · filed 2020-03-05 | -$57.46M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2018-03-31 | -$15.70M 10-Q · filed 2019-05-09 | -$29.06M derived: sum of 2 quarters · filed 2020-03-05 | -$41.90M derived: sum of 3 quarters · filed 2020-03-05 | -$55.44M derived: sum of 4 quarters · filed 2020-03-05 | ||||
| 2017-12-31 | -$13.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | -$26.20M derived: sum of 2 quarters · filed 2020-03-05 | -$39.73M derived: sum of 3 quarters · filed 2020-03-05 | -$53.00M 10-K · filed 2020-03-05 | ||||
| 2017-09-30 | -$12.84M 10-Q · filed 2018-11-09 | -$26.38M derived: sum of 2 quarters · filed 2018-11-09 | -$39.64M 10-Q · filed 2018-11-09 | -$50.12M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-06-30 | -$13.54M 10-Q · filed 2018-08-09 | -$26.80M 10-Q · filed 2018-08-09 | -$37.28M derived: sum of 3 quarters · filed 2019-03-14 | -$52.11M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-03-31 | -$13.27M 10-Q · filed 2018-05-10 | -$23.74M derived: sum of 2 quarters · filed 2019-03-14 | -$38.57M derived: sum of 3 quarters · filed 2019-03-14 | -$53.63M derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2016-12-31 | -$10.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$25.31M derived: sum of 2 quarters · filed 2019-03-14 | -$40.37M derived: sum of 3 quarters · filed 2019-03-14 | -$58.23M 10-K · filed 2019-03-14 | ||||
| 2016-09-30 | -$14.83M 10-Q · filed 2017-11-07 | -$29.89M derived: sum of 2 quarters · filed 2017-11-07 | -$47.75M 10-Q · filed 2017-11-07 | -$71.00M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-06-30 | -$15.06M 10-Q · filed 2017-08-09 | -$32.92M 10-Q · filed 2017-08-09 | -$56.16M derived: sum of 3 quarters · filed 2018-03-09 | -$75.88M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-03-31 | -$17.86M 10-Q · filed 2017-05-09 | -$41.10M derived: sum of 2 quarters · filed 2018-03-09 | -$60.82M derived: sum of 3 quarters · filed 2018-03-09 | -$78.43M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2015-12-31 | -$23.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$42.96M derived: sum of 2 quarters · filed 2018-03-09 | -$60.57M derived: sum of 3 quarters · filed 2018-03-09 | -$73.81M 10-K · filed 2018-03-09 | ||||
| 2015-09-30 | -$19.72M 10-Q · filed 2016-11-09 | -$37.33M derived: sum of 2 quarters · filed 2016-11-09 | -$50.57M 10-Q · filed 2016-11-09 | -$61.23M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-06-30 | -$17.61M 10-Q · filed 2016-08-05 | -$30.85M 10-Q · filed 2016-08-05 | -$41.51M derived: sum of 3 quarters · filed 2017-03-10 | -$55.88M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2015-03-31 | -$13.24M 10-Q · filed 2016-05-10 | -$23.90M derived: sum of 2 quarters · filed 2017-03-10 | -$38.27M derived: sum of 3 quarters · filed 2017-03-10 | -$44.25M derived: sum of 4 quarters · filed 2017-03-10 | ||||
| 2014-12-31 | -$10.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$25.02M derived: sum of 2 quarters · filed 2017-03-10 | -$31.01M derived: sum of 3 quarters · filed 2017-03-10 | -$35.53M 10-K · filed 2017-03-10 | ||||
| 2014-09-30 | -$14.36M 10-Q · filed 2015-11-13 | -$20.35M derived: sum of 2 quarters · filed 2015-08-14 | -$24.87M 10-Q · filed 2015-11-13 | -$28.63M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | -$5.99M 10-Q · filed 2015-08-14 | -$10.51M 10-Q · filed 2015-08-14 | -$14.27M derived: sum of 3 quarters · filed 2016-03-15 | -$17.79M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | -$4.52M 10-Q · filed 2015-05-14 | -$8.28M derived: sum of 2 quarters · filed 2016-03-15 | -$11.81M derived: sum of 3 quarters · filed 2016-03-15 | -$14.78M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | -$3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$7.29M derived: sum of 2 quarters · filed 2016-03-15 | -$10.26M derived: sum of 3 quarters · filed 2016-03-15 | -$13.78M 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | -$3.52M 10-Q · filed 2014-11-13 | -$6.50M derived: sum of 2 quarters · filed 2014-11-13 | -$10.02M 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | -$2.98M 10-Q · filed 2014-08-14 | -$6.50M 10-Q · filed 2014-08-14 | ||||||
| 2012-12-31 | -$13.79M 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |